Trastuzumab (Herceptin®) in patients with HER-2-overexpressing metastatic or locally advanced transitional cell carcinoma of the bladder: report on 7 patientsMarc Salzberg, Christoph Rochlitz, Daniel Rauch et al.|European Journal of Cancer|2006Cited by 22
Quality of Life in Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer Using Cabazitaxel or Other Therapies After Previous Docetaxel Chemotherapy: Swiss Observational Treatment RegistryFrank Stenner, Richard Cathomas, Sacha I. Rothschild et al.|Clinical Genitourinary Cancer|2017Cited by 7